Мать и Дитя logo
Мать и Дитя MDMG
report update icon

Quarterly report 2026-Q2
added 09-06-2026

Мать и Дитя Financial Statements 2025-2011 | MDMG

Key Metrics Мать и Дитя

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Operating Cash Flow Per Share

185 148 125 103 113 86.7 65.8 55.6 55.9 51.5 37.6 28.1 21.4 0.025 17.2

Free Cash Flow Per Share

134 128 80 87.4 62.7 34.8 12.7 6.35 9.66 28.2 27.1 -13.7 -11 -0.012 -11.8

Cash Per Share

36.4 80.6 132 59.4 47.8 51.6 47.5 36.2 33.4 21.9 23.7 11.9 43.6 0.07 2.14

Price To Sales Ratio

3 2 2 1.23 2.37 1.77 1.44 1.57 3.32 3.58 2.95 3.39 4.92 6.77 K 8.35

Dividend Yield

0.059 0.228 - 0.021 0.046 0.065 0.034 0.021 0.015 0.018 0.011 0.007 0.011 0.0 0.0

Payout Ratio

0.62 2 - 0.14 0.454 0.527 0.299 0.185 0.274 0.38 0.187 0.151 0.493 0.11 0.002

Revenue Per Share

579 441 368 336 336 255 215 199 184 163 127 96 75.5 0.056 46.5

Net Income Per Share

143 132 104 60.7 79.9 55.9 35.1 35.6 33.2 27.6 21.4 15.9 8.47 0.019 13.8

Book Value Per Share

392 378 431 359 307 266 238 213 195 171 154 135 123 0.12 44.9

Tangible Book Value Per Share

392 378 431 333 279 236 209 183 163 138 125 109 117 0.119 44.4

Shareholders Equity Per Share

392 378 431 356 304 261 233 209 189 165 148 130 117 0.115 41.3

Interest Debt Per Share

41.3 - 11.7 13 80 97.2 101 80.6 64.9 48 51.1 58.8 43.7 0.041 19.6

Market Cap

112 B 67.5 B 58.2 B 31 B 59.8 B 33.9 B 23.2 B 23.5 B 45.6 B 43.6 B 28.1 B 24.4 B 27.9 B 27.5 T 24.3 B

Enterprise Value

110 B 61.5 B 49.2 B 27.2 B 61.7 B 37.6 B 27.2 B 26.4 B 47.7 B 45.2 B 29.8 B 27.7 B 27.6 B 27.5 T 25.3 B

P/E Ratio

10 7 7 6.81 9.96 8.08 8.8 8.79 18.3 21.1 17.5 20.4 43.9 19.6 K 28.2

P/OCF Ratio

8.09 6.08 6.2 4.01 7.03 5.2 4.69 5.63 10.9 11.3 9.97 11.6 17.3 15.1 K 22.6

P/FCF Ratio

11.7 7.64 10 4.73 12.7 13 24.3 49.2 63.1 20.6 13.8 -23.8 -33.9 -33.1 K -32.9

P/B Ratio

4 2 2 1.16 2.62 1.73 1.32 1.5 3.22 3.53 2.53 2.51 3.17 3.32 K 9.41

EV/Sales

2.52 1.86 1.78 1.08 2.45 1.96 1.69 1.77 3.47 3.71 3.13 3.84 4.87 6.77 K 8.71

EV/EBITDA

8 6 5 3.34 7.34 6.09 5.71 5.93 11.4 12.9 9.75 12.3 17.9 16.3 K 19.1

EV/OCF

7.9 5.54 5.25 3.51 7.26 5.77 5.51 6.34 11.4 11.7 10.6 13.1 17.2 15.1 K 23.5

Earnings Yield

0.096 0.147 0.134 0.147 0.1 0.124 0.114 0.114 0.055 0.047 0.057 0.049 0.023 0.0 0.035

Free Cash Flow Yield

0.089 0.143 0.103 0.211 0.079 0.077 0.041 0.02 0.016 0.049 0.072 -0.042 -0.029 -0.0 -0.03

Debt To Equity

0.105 - 0.027 0.022 0.241 0.348 0.405 0.361 0.323 0.267 0.312 0.422 0.341 0.357 0.462

Debt To Assets

0.062 - 0.021 0.018 0.161 0.213 0.248 0.226 0.205 0.176 0.201 0.256 0.22 0.229 0.25

Net Debt To EBITDA

-0.2 -0.57 -0.98 -0.475 0.229 0.598 0.846 0.662 0.495 0.47 0.553 1.43 -0.177 0.223 0.799

Current Ratio

- - - 1.46 0.899 1.04 1.19 1.05 1.01 0.768 0.82 0.564 1.79 3.62 0.283

Interest Coverage

- - - 13.1 13.4 9.37 6.2 8.12 11.1 9.02 4.83 5.26 4.15 57.3 39.6

Income Quality

1.29 1.12 1.2 1.64 1.38 1.5 1.77 1.47 1.55 1.7 1.59 1.6 2.11 1.18 1.16

Sales General And Administrative To Revenue

0.439 0.417 0.402 0.01 0.008 0.011 0.014 0.019 0.021 0.019 0.024 0.03 0.029 0.02 0.084

Intangibles To Total Assets

- - - 0.059 0.062 0.069 0.076 0.09 0.105 0.13 0.125 0.123 0.033 0.002 0.006

Capex To Operating Cash Flow

0.307 0.205 0.382 0.151 0.446 0.599 0.807 0.886 0.827 0.453 0.28 1.49 1.51 1.46 1.69

Capex To Revenue

0.1 0.07 0.13 0.046 0.15 0.204 0.247 0.247 0.252 0.143 0.083 0.435 0.429 0.652 0.623

Capex To Depreciation

1.52 1.19 2.11 0.701 2.23 2.56 2.65 3.1 3.34 1.85 0.894 5.73 5.68 19.7 18.3

Stock Based Compensation To Revenue

- - - - - - - 0.0 0.003 0.002 0.003 - - - -

Graham Number

- - - 697 739 573 429 409 376 320 267 216 149 0.224 113

Return On Invested Capital, ROIC

- - - 0.181 0.233 0.17 0.129 0.145 0.168 0.177 0.12 0.105 0.09 0.141 0.245

Return On Tangible Assets, ROTA

0.217 0.255 0.189 0.146 0.187 0.141 0.1 0.117 0.125 0.127 0.106 0.085 0.048 0.109 0.181

Graham Net Net

- - - -15 -93.4 -102 -91.3 -80.4 -61.7 -54.5 -50.2 -65.5 -14.8 0.01 -29

Working Capital

- - - 2.07 B -641 M 213 M 779 M 197 M 33.3 M -756 M -529 M -1.11 B 1.57 B 3.84 B -589 M

Tangible Asset Value

29.4 B 28.4 B 32.4 B 25 B 21 B 17.7 B 15.7 B 13.7 B 12.2 B 10.3 B 9.36 B 8.16 B 8.76 B 8.59 B 2.78 B

Net Current Asset Value, NCAV

- - - 388 M -5.46 B -6.19 B -5.84 B -5.24 B -4.22 B -3.44 B -3.29 B -4.5 B -894 M 1.02 B -1.73 B

Invested Capital

29.4 B 28.4 B 33.3 B 28.7 B 27.9 B 26.3 B 24.5 B 20.6 B 17.7 B 15.1 B 14 B 13.4 B 11.2 B 11.3 B 3.49 B

Average Receivables

- - - - - - - 211 M 211 M - - - - - -

Average Payables

- - - 2.92 B 2.82 B 2.18 B 1.56 B 1.36 B 1.24 B 1.01 B 886 M 823 M 752 M 538 M -

Average Inventory

- - - 1.19 B 1.07 B 847 M 693 M 596 M 485 M 386 M 298 M 189 M 80.7 M 38.8 M -

Days Sales Outstanding

- - - - - - - - 11.2 - - - - - -

Days Payables Outstanding

- - - 66.8 72.1 80 61 53.9 58.2 56.8 53.9 77.5 80.6 137 79.9

Days Of Inventory On Hand

- - - 28.7 27.9 29.6 25.3 25.9 22.9 22 20.2 23.1 11.9 9.15 6.75

Receivables Turnover

- - - - - - - - 32.7 - - - - - -

Payables Turnover

- - - 5.47 5.06 4.56 5.98 6.77 6.27 6.42 6.78 4.71 4.53 2.66 4.57

Inventory Turnover

- - - 12.7 13.1 12.3 14.4 14.1 15.9 16.6 18.1 15.8 30.6 39.9 54.1

Return On Equity, ROE

0.295 0.325 0.226 0.17 0.263 0.214 0.15 0.17 0.176 0.167 0.145 0.123 0.072 0.169 0.333

Capex Per Share

56.9 30.2 47.7 15.6 50.5 52 53.1 49.2 46.2 23.3 10.5 41.8 32.4 0.037 29

All numbers in RUB currency

Quarterly Key Metrics Мать и Дитя

2026-Q2 2026-Q1 2025-Q4 2025-Q3 2025-Q2

Price To Sales Ratio

1.96 2.25 2.59 2.3 2.11

Market Cap

96 B 104 B 112 B 91.8 B 77.2 B

Enterprise Value

102 B 100 B 113 B 88 B 73.8 B

P/E Ratio

8.73 9.72 10.5 9.2 7.74

P/B Ratio

3.55 - 3.82 - 2.91

EV/EBITDA

6.77 7.36 8.28 7.69 6.45

Return On Equity, ROE

0.288 - 0.295 - 0.295

All numbers in RUB currency

Financial statements are the primary tool companies use to inform stakeholders about their financial position, performance, and changes in capital structure. It is a kind of "business language" understood by investors, creditors, tax authorities, and other participants in the economic environment.

Main types of financial statements Мать и Дитя MDMG
  1. Income Statement
    Shows income, expenses, and resulting profit or loss over a specific period. Helps assess business profitability.
  2. Balance Sheet
    Reflects a company’s assets, liabilities, and equity as of a specific date. It’s a snapshot of what the company owns and owes.
    Assets — everything the company owns (cash, equipment, buildings, accounts receivable, etc.).
    Liabilities — debts and other external sources of financing.
    Equity — owners' capital and retained earnings.
  3. Cash Flow Statement
    Reveals how the company earns and spends money in three areas: operating, investing, and financing activities.
International reporting standards
  • IFRS — International Financial Reporting Standards, applicable to public and multinational companies.
  • GAAP — Generally Accepted Accounting Principles used in the United States.
  • RAS — Russian Accounting Standards, used domestically in Russia.

Financial reporting Мать и Дитя plays a crucial role for investors as it serves as an objective source of information about a company's current state. Based on the reports, one can determine whether a company is growing, stagnating, or losing market share. This allows investors to identify both promising and problematic assets in a timely manner.

In addition, financial data provides a basis for forecasting future returns. Historical trends in revenue, profit, and cash flow help evaluate potential dividends, the likelihood of stock price growth, and overall investment risk.

Transparent and accurate reporting is also an indicator of a company’s maturity and managerial responsibility. Such openness builds investor confidence and simplifies investment decision-making, especially when comparing multiple companies.

Finally, financial statements enable high-quality comparative analysis. They allow companies to be evaluated against each other in terms of profitability, debt levels, margins, and other key metrics — which is particularly important when choosing the best investment options within an industry or market segment.

Financial statements of other stocks in the Care facilities industry

Issuer Price % 24h Market Cap Country
Capital Senior Living Corporation Capital Senior Living Corporation
CSU
- -2.09 % $ 216 M usaUSA
New Frontier Health Corporation New Frontier Health Corporation
NFH
- 3.54 % $ 1.5 B usaUSA
Aesthetic Medical International Holdings Group Limited Aesthetic Medical International Holdings Group Limited
AIH
- 10.96 % $ 46.2 M chinaChina
ЮМГ ЮМГ
GEMC
- - - russiaRussia
Concord Medical Services Holdings Limited Concord Medical Services Holdings Limited
CCM
$ 4.68 1.08 % $ 613 M chinaChina
Five Star Senior Living Inc. Five Star Senior Living Inc.
FVE
- -0.32 % $ 98.4 M usaUSA
Fresenius Medical Care AG & Co. KGaA Fresenius Medical Care AG & Co. KGaA
FMS
$ 22.66 0.85 % $ 6.6 B germanyGermany
LHC Group LHC Group
LHCG
- - $ 5.27 B usaUSA
Oak Street Health Oak Street Health
OSH
- 0.03 % $ 9.53 B usaUSA
Genesis Healthcare, Inc. Genesis Healthcare, Inc.
GEN
- - $ 68.1 M usaUSA
Avalon GloboCare Corp. Avalon GloboCare Corp.
AVCO
- 26.45 % $ 70.6 M usaUSA
Acadia Healthcare Company Acadia Healthcare Company
ACHC
$ 28.13 0.67 % $ 2.55 B usaUSA
Addus HomeCare Corporation Addus HomeCare Corporation
ADUS
$ 118.76 0.06 % $ 2.14 B usaUSA
Amedisys Amedisys
AMED
- 0.01 % $ 3.3 B usaUSA
Apollo Medical Holdings Apollo Medical Holdings
AMEH
- -2.11 % $ 1.84 B usaUSA
AMN Healthcare Services AMN Healthcare Services
AMN
$ 33.8 1.3 % $ 1.3 B usaUSA
American Shared Hospital Services American Shared Hospital Services
AMS
$ 1.43 1.39 % $ 9.46 M usaUSA
Brookdale Senior Living Brookdale Senior Living
BKD
$ 11.77 0.08 % $ 2.77 B usaUSA
Chemed Corporation Chemed Corporation
CHE
$ 519.84 0.09 % $ 7.48 B usaUSA
COMPASS Pathways plc COMPASS Pathways plc
CMPS
$ 13.27 0.08 % $ 1.24 B britainBritain
Community Health Systems Community Health Systems
CYH
$ 2.89 0.34 % $ 386 M usaUSA
DaVita DaVita
DVA
$ 183.99 1.19 % $ 13.7 B usaUSA
Encompass Health Corporation Encompass Health Corporation
EHC
$ 121.79 0.01 % $ 12.2 B usaUSA
Elanco Animal Health Incorporated Elanco Animal Health Incorporated
ELAN
$ 24.5 0.33 % $ 12.2 B usaUSA
The Ensign Group The Ensign Group
ENSG
$ 170.79 0.22 % $ 9.79 B usaUSA
HCA Healthcare HCA Healthcare
HCA
$ 405.0 1.78 % $ 95.7 B usaUSA
Healthcare Services Group Healthcare Services Group
HCSG
$ 21.82 0.51 % $ 1.58 B usaUSA
Hanger Hanger
HNGR
- - $ 732 M usaUSA
IMAC Holdings IMAC Holdings
IMAC
- -1.77 % $ 25.4 M usaUSA
The Joint Corp. The Joint Corp.
JYNT
$ 8.32 0.48 % $ 126 M usaUSA
MEDNAX MEDNAX
MD
$ 27.03 0.52 % $ 2.27 B usaUSA
ModivCare ModivCare
MODV
- -25.23 % $ 6.12 M usaUSA
National HealthCare Corporation National HealthCare Corporation
NHC
$ 218.64 0.01 % $ 3.38 B usaUSA
Novo Integrated Sciences Novo Integrated Sciences
NVOS
- -13.87 % $ 1.52 M usaUSA
Option Care Health Option Care Health
OPCH
$ 24.21 2.56 % $ 3.92 B usaUSA
Ontrak Ontrak
OTRK
- -11.98 % $ 1.53 M usaUSA
Phibro Animal Health Corporation Phibro Animal Health Corporation
PAHC
$ 38.25 0.06 % $ 1.55 B usaUSA
The Pennant Group The Pennant Group
PNTG
$ 38.0 1.8 % $ 1.31 B usaUSA
Regional Health Properties Regional Health Properties
RHE
- - $ 5.2 M usaUSA
Select Medical Holdings Corporation Select Medical Holdings Corporation
SEM
- - $ 2.02 B usaUSA
Surgery Partners Surgery Partners
SGRY
$ 14.26 0.64 % $ 1.81 B usaUSA
Sanara MedTech Sanara MedTech
SMTI
$ 34.73 0.03 % $ 299 M usaUSA
SunLink Health Systems SunLink Health Systems
SSY
- 17.98 % $ 7.81 M usaUSA
Tenet Healthcare Corporation Tenet Healthcare Corporation
THC
$ 265.05 0.59 % $ 23.9 B usaUSA
Tivity Health Tivity Health
TVTY
- 0.09 % $ 1.6 B usaUSA
Universal Health Services Universal Health Services
UHS
$ 169.65 0.31 % $ 10.8 B usaUSA
U.S. Physical Therapy U.S. Physical Therapy
USPH
$ 79.35 0.9 % $ 1.2 B usaUSA